{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:09:16Z","timestamp":1794474556571,"version":"4.9.1"},"reference-count":39,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2014NextGenerationEU","award":["NPOO.C3.2.R3-I1.04.0266"],"award-info":[{"award-number":["NPOO.C3.2.R3-I1.04.0266"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: MicroRNAs (miRNAs) regulate gene expression and are proposed as biomarkers in colorectal cancer (CRC). This study evaluated miR-185-5p, miR-141-5p, and miR-21-5p expression in CRC tissues; their association with tumor location, histopathology, and clinical outcomes; and the suitability of miR-16-5p and miR-151a-3p as housekeeping controls. Previous reports suggest tumor-suppressive roles for miR-185 and miR-141 and an oncogenic function for miR-21, though findings remain inconsistent. Methods: Paired tumor and adjacent normal tissues from 70 CRC patients were analyzed. RNA was extracted from FFPE samples, and miRNA expression quantified by RT-qPCR. Relative expression values were normalized to miR-151a-3p. Tumor\u2013normal differences, localization effects, and associations with clinicopathological and outcome variables were assessed using repeated-measures ANOVA and non-parametric tests. Results: miR-185-5p and miR-141-5p were significantly reduced in tumors compared with normal mucosa while miR-21-5p was upregulated. miR-16-5p showed higher expression in normal tissue, indicating its instability and unsuitability as a housekeeping control. A modest but significant localization effect was observed for miR-185, while other miRNAs were minimally influenced by location. Baseline asymmetry between non-tumor samples, observed for miR-185-5p, further indicated sidedness effects. None of the miRNAs were associated with stage, histological type, grade, invasion, immune infiltration, progression, or five-year survival. Conclusions: miR-185-5p, miR-141-5p, and miR-21-5p show robust tumor\u2013normal differences, supporting their diagnostic potential, while miR-16-5p is unsuitable as a housekeeper. Modest but significant localization effect was observed for miR-185 in right-sided tumors. None showed prognostic value in stage I\u2013III CRC. Larger, location-stratified studies are warranted.<\/jats:p>","DOI":"10.3390\/biomedicines13102460","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:45:01Z","timestamp":1760089501000},"page":"2460","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic Relevance of miR-185, miR-141, and miR-21 in Colon Carcinoma: Insights into Tumor Sidedness and Reference Gene Selection"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3128-4830","authenticated-orcid":false,"given":"Dorian","family":"Kr\u0161ul","sequence":"first","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Prenc","sequence":"additional","affiliation":[{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Po\u017egaj","sequence":"additional","affiliation":[{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"\u0160tefok","sequence":"additional","affiliation":[{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Pongrac","sequence":"additional","affiliation":[{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4507-4997","authenticated-orcid":false,"given":"Marija","family":"Podolski","sequence":"additional","affiliation":[{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Paravi\u0107","family":"Radi\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-0198","authenticated-orcid":false,"given":"Damir","family":"Karlovi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Jerkovi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3388-4813","authenticated-orcid":false,"given":"Marin","family":"Gol\u010di\u0107","sequence":"additional","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-996X","authenticated-orcid":false,"given":"Ivan","family":"Dra\u017ei\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, University of Rijeka, Vukovarska 58, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Glava\u0161 Kr\u0161ul","sequence":"additional","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Fu\u010dkar \u010cupi\u0107","sequence":"additional","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Erakovi\u0107 Haber","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"},{"name":"Selvita Ltd., Prilaz baruna Filipovi\u0107a 29, 10000 Zagreb, Croatia"},{"name":"Faculty of Biotechnology and Drug Development, University of Rijeka, Radmile Matej\u010di\u0107 2, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-3180","authenticated-orcid":false,"given":"Marko","family":"Zeli\u0107","sequence":"additional","affiliation":[{"name":"Clinical Hospital Center Rijeka, Kre\u0161imirova 42, 51000 Rijeka, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, Bra\u0107e Branchetta 20, 51000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global Burden of 5 Major Types of Gastrointestinal Cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Duan, B., Zhao, Y., Bai, J., Wang, J., Duan, X., Luo, X., Zhang, R., Pu, Y., Kou, M., and Lei, J. (2022). Colorectal Cancer: An Overview. Gastrointestinal Cancers, Exon Publications.","DOI":"10.36255\/exon-publications-gastrointestinal-cancers-colorectal-cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOG.0000000000000988","article-title":"Colon polyps: Updates in classification and management","volume":"40","author":"Dornblaser","year":"2024","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","article-title":"Pathways of Colorectal Carcinogenesis","volume":"158","author":"Nguyen","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_6","unstructured":"Menon, G., Recio-Boiles, A., Lotfollahzadeh, S., and Cagir, B. (2024). Colon Cancer, StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/gutjnl-2020-321534","article-title":"Genetic architectures of proximal and distal colorectal cancer are partly distinct","volume":"70","author":"Huyghe","year":"2021","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Paschke, S., Jafarov, S., Staib, L., Kreuser, E.D., Maulbecker-Armstrong, C., Roitman, M., Holm, T., Harris, C.C., Link, K.-H., and Kornmann, M. (2018). Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092577"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.6004\/jnccn.2017.0038","article-title":"Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes","volume":"15","author":"Lee","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.21873\/anticanres.14360","article-title":"MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer","volume":"40","author":"Eneh","year":"2020","journal-title":"Anticancer. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14737140.2018.1442217","article-title":"Difference between right-sided and left-sided colorectal cancers: From embryology to molecular subtype","volume":"18","author":"Yang","year":"2018","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21991","DOI":"10.18632\/aging.203556","article-title":"Identification of colorectal cancer associated biomarkers: An integrated analysis of miRNA expression","volume":"13","author":"Fonseca","year":"2021","journal-title":"Aging"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Danese, E., Minicozzi, A.M., Benati, M., Paviati, E., Lima-Oliveira, G., Gusella, M., Pasini, F., Salvagno, G.L., Montagnana, M., and Lippi, G. (2017). Reference miRNAs for colorectal cancer: Analysis and verification of current data. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-08784-3"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chang, K.H., Mestdagh, P., Vandesompele, J., Kerin, M.J., and Miller, N. (2010). MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-173"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Burdiel, M., Jim\u00e9nez, J., Rodr\u00edguez-Antol\u00edn, C., Garc\u00eda-Guede, \u00c1., Pern\u00eda, O., Sastre-Perona, A., Rosas-Alonso, R., Colmenarejo, J., Rodr\u00edguez-Jim\u00e9nez, C., and Diestro, M.D. (2023). MiR-151a: A robust endogenous control for normalizing small extracellular vesicle cargo in human cancer. Biomark. Res., 11.","DOI":"10.1186\/s40364-023-00526-0"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.4081\/ejh.2022.3333","article-title":"microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K\/Akt\/mTOR pathway","volume":"66","author":"Huang","year":"2022","journal-title":"Eur. J. Histochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Khoshbakht","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Babaeenezhad, E., Naghibalhossaini, F., Rajabibazl, M., Jangravi, Z., Hadipour Moradi, F., Fattahi, M.D., Hoheisel, J.D., Sarabi, M.M., and Shahryarhesami, S. (2022). The Roles of microRNA miR-185 in Digestive Tract Cancers. Noncoding RNA, 8.","DOI":"10.3390\/ncrna8050067"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/0019-509X.186576","article-title":"MicroRNA-185 is a novel tumor suppressor by negatively modulating the Wnt\/\u03b2-catenin pathway in human colorectal cancer","volume":"52","author":"Jia","year":"2015","journal-title":"Indian J. Cancer"},{"key":"ref_21","first-page":"311","article-title":"miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer","volume":"39","author":"Akcakaya","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2018.02.019","article-title":"miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer","volume":"825","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2010.11.009","article-title":"miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells","volume":"301","author":"Liu","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33901","DOI":"10.1074\/jbc.M111.262030","article-title":"Autoregulatory Suppression of c-Myc by miR-185-3p","volume":"286","author":"Liao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/15384047.2020.1761238","article-title":"MiR-185-3p mimic promotes the chemosensitivity of CRC cells via AQP5","volume":"21","author":"Zhou","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopha.2018.07.002","article-title":"MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2","volume":"106","author":"Afshar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbrc.2019.05.002","article-title":"MiR-141\u20133p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer","volume":"514","author":"Liang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/ijc.31282","article-title":"The role of the miR--200 family in epithelial\u2013mesenchymal transition in colorectal cancer: A systematic review","volume":"142","author":"Carter","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_31","first-page":"2665","article-title":"The role of miR-141\/Sirt1 in colon cancer","volume":"25","author":"Li","year":"2020","journal-title":"J. Buon."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10238-025-01582-6","article-title":"The role of miRNAs in the pathogenesis, diagnosis, and treatment of colorectal cancer and colitis-associated cancer","volume":"25","author":"Basak","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Schee, K., Boye, K., Abrahamsen, T.W., Fodstad, \u00d8., and Flatmark, K. (2012). Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-505"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/bjc.2012.365","article-title":"The prognostic importance of miR-21 in stage II colon cancer: A population-based study","volume":"107","author":"Hansen","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2017.02.049","article-title":"NR2F2 inhibits Smad7 expression and promotes TGF-\u03b2-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21","volume":"485","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10585-018-9945-3","article-title":"miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy","volume":"35","author":"Knudsen","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10585-010-9355-7","article-title":"High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients","volume":"28","author":"Nielsen","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-021-03672-1","article-title":"Impaired AGO2\/miR-185-3p\/NRP1 axis promotes colorectal cancer metastasis","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2460\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:31:17Z","timestamp":1760092277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["biomedicines13102460"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13102460","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]}}}